Huang RY - Search Results

1

The clinical role of epithelial-mesenchymal transition and stem cell markers in advanced-stage ovarian serous carcinoma effusions.

Davidson B, Holth A, Hellesylt E, Tan TZ, Huang RY, Tropé C, Nesland JM, Thiery JP. Davidson B, et al. Among authors: huang ry. Hum Pathol. 2015 Jan;46(1):1-8. doi: 10.1016/j.humpath.2014.10.004. Epub 2014 Oct 16. Hum Pathol. 2015. PMID: 25455994

2

Linking epithelial-mesenchymal transition to the well-known polarity protein Par6.

Thiery JP, Huang R. Thiery JP, et al. Dev Cell. 2005 Apr;8(4):456-8. doi: 10.1016/j.devcel.2005.03.002. Dev Cell. 2005. PMID: 15809027 Free article.

3

Target cell movement in tumor and cardiovascular diseases based on the epithelial-mesenchymal transition concept.

Chua KN, Poon KL, Lim J, Sim WJ, Huang RY, Thiery JP. Chua KN, et al. Among authors: huang ry. Adv Drug Deliv Rev. 2011 Jul 18;63(8):558-67. doi: 10.1016/j.addr.2011.02.003. Epub 2011 Feb 16. Adv Drug Deliv Rev. 2011. PMID: 21335038 Review.

4

Targeting pathways contributing to epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer.

Huang RY, Chung VY, Thiery JP. Huang RY, et al. Curr Drug Targets. 2012 Dec;13(13):1649-53. doi: 10.2174/138945012803530044. Curr Drug Targets. 2012. PMID: 23061545 Review.

5

Early events in cell adhesion and polarity during epithelial-mesenchymal transition.

Huang RY, Guilford P, Thiery JP. Huang RY, et al. J Cell Sci. 2012 Oct 1;125(Pt 19):4417-22. doi: 10.1242/jcs.099697. J Cell Sci. 2012. PMID: 23165231 Review. No abstract available.

6

Screening therapeutic EMT blocking agents in a three-dimensional microenvironment.

Aref AR, Huang RY, Yu W, Chua KN, Sun W, Tu TY, Bai J, Sim WJ, Zervantonakis IK, Thiery JP, Kamm RD. Aref AR, et al. Among authors: huang ry. Integr Biol (Camb). 2013 Feb;5(2):381-9. doi: 10.1039/c2ib20209c. Integr Biol (Camb). 2013. PMID: 23172153 Free PMC article.

7

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer.

Tan TZ, Miow QH, Huang RY, Wong MK, Ye J, Lau JA, Wu MC, Bin Abdul Hadi LH, Soong R, Choolani M, Davidson B, Nesland JM, Wang LZ, Matsumura N, Mandai M, Konishi I, Goh BC, Chang JT, Thiery JP, Mori S. Tan TZ, et al. Among authors: huang ry. EMBO Mol Med. 2013 Jul;5(7):1051-66. doi: 10.1002/emmm.201201823. Epub 2013 May 13. EMBO Mol Med. 2013. PMID: 23666744 Free PMC article.

8

Lgr5 marks stem/progenitor cells in ovary and tubal epithelia.

Ng A, Tan S, Singh G, Rizk P, Swathi Y, Tan TZ, Huang RY, Leushacke M, Barker N. Ng A, et al. Among authors: huang ry. Nat Cell Biol. 2014 Aug;16(8):745-57. doi: 10.1038/ncb3000. Epub 2014 Jul 6. Nat Cell Biol. 2014. PMID: 24997521

9

Epithelial-mesenchymal transition spectrum quantification and its efficacy in deciphering survival and drug responses of cancer patients.

Tan TZ, Miow QH, Miki Y, Noda T, Mori S, Huang RY, Thiery JP. Tan TZ, et al. Among authors: huang ry. EMBO Mol Med. 2014 Oct;6(10):1279-93. doi: 10.15252/emmm.201404208. EMBO Mol Med. 2014. PMID: 25214461 Free PMC article.

10

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120).

Huang RY, Kuay KT, Tan TZ, Asad M, Tang HM, Ng AH, Ye J, Chung VY, Thiery JP. Huang RY, et al. Oncotarget. 2015 Sep 8;6(26):22098-113. doi: 10.18632/oncotarget.4300. Oncotarget. 2015. PMID: 26061747 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

567 results

Search Page